PLUS1
2.34
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cerecor Inc | CERC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.16 | 7.34% | 2.34 | 2.22 | 2.46 | 2.26 | 2.18 | 18:00:25 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.91 | 2.47 | 0.56 | 22.67% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,112 | 146,069 | $ 2.33 | $ 340,375 | 148,123 | 1.5476 - 6.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:22 | 2 | $ 2.34 | USD |
Cerecor Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 146.06M | 62.42M | $ -40.05M | -0.28 | - | 59.85M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 8.00 | 4.10% |
Cerecor News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/02/2020 | 18:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 4/02/2020 | 17:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 4/02/2020 | 16:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/31/2020 | 17:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/27/2020 | 16:03 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 3/26/2020 | 06:30 | GlobeNewswire Inc. | Cerecor Announces Exploration of the Role of an Inflammatory.. |
| 3/24/2020 | 16:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CERC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.40 | 2.59 | 2.03 | 2.32 | 155,070 | -0.06 | -2.5% |
| 1 Month | 2.55 | 3.50 | 1.5476 | 2.40 | 165,437 | -0.21 | -8.24% |
| 3 Months | 4.93 | 5.20 | 1.5476 | 3.08 | 109,063 | -2.59 | -52.54% |
| 6 Months | 3.15 | 6.19 | 1.5476 | 3.66 | 95,282 | -0.81 | -25.71% |
| 1 Year | 5.63 | 6.50 | 1.5476 | 4.07 | 92,602 | -3.29 | -58.44% |
| 3 Years | 0.53 | 7.6499 | 0.3401 | 2.36 | 258,448 | 1.81 | 341.51% |
| 5 Years | 4.95 | 7.6499 | 0.3401 | 2.28 | 215,484 | -2.61 | -52.73% |
Cerecor Description
| Cerecor Inc is a biopharmaceutical company with commercial operations and research and development capabilities. The Company is building a robust pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases. The Company is also developing three other neurological clinical and preclinical stage compounds. The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802 and CERC-803. The Company also markets prescription drugs that treat a range of pediatric diseases, disorders and conditions. Cerecor's prescription drugs include Millipred, Ulesfia, Karbinal ER, AcipHex Sprinkle and Cefaclor for Oral Suspension. The Company has marketed medical device, Flexichamber. |
